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ABSTRACT 
Objective: To assess sociodemographic factors and cancer information on patients' quality of life with head 
and neck cancer. Material and Methods: This cross-sectional study was conducted on 69 patients with 
head and neck cancer who attended in one of the oncology centers in Mashhad, Iran, from September 2019 
to December 2019. Data was collected through a questionnaire consisted of demographic information 
(gender, age, educational level, and job) and cancer information (type, location, treatment, clinical stage) and 
standard quality of life questionnaire (QLQ-H&N35). Data analyzed in SPSS22 software using T, ANOVA, 
Linear regression tests at 0.05 significant levels. Results: 49 participants (72.1%) were men. The mean age 
was 60.48 ± 13.74 years. Forty-nine participants (72.1%) had squamous cell carcinoma and 26 participants 
(38.2%) had a larynx tumor. Forty-six participants (67.6%) were in clinical stage 3, mainly with a problem 
and complain about hard food swallowing, xerostomia and speech. The mean score of QLQ-H&N35 was 
42.06 ± 20.12 from 90. Quality of life in 47.1% of cases was moderate. There was no significant relationship 
between gender, job, educational level, type and location of cancer (p>0.05). There was a significant 
relationship between the patient's age, clinical stage, type of treatment, and quality of life (p<0.05). 
Conclusion: Quality of life in 47.1% was moderate. Clinical stage, age of patients and type of treatment 
statically and significantly affected the quality of life. Assessing quality of life in HNC patients can identify 
important side effects of treatment that affected quality of life and look for ways to improve QoL. 
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Introduction 
Head and neck cancer includes lip, mouth, tongue, tonsil, pharynx, larynx, hypopharynx, and salivary 
glands and because determining their boundaries is difficult contrary to other parts of the body, it is an 
important challenge [1]. Head and neck cancers are the 10th most common cancers worldwide [2]. The 
studies indicate the increase of oral cancer worldwide [3], and it is a major problem of global health that more 
than two-thirds of deaths caused by it can be seen in developing countries [4]. 
The unpleasant side effects on the quality of life (QoL) in the patients with head and neck cancers are 
higher than other cancers because the key functions are affected due to the disease and its treatment [5]. The 
treatment side effects of head and neck cancer are pain, mucositis, xerostomia, loss of olfactory and gustatory 
sense, anorexia, and weight loss, affecting a patient's quality of life [6]. 
Many factors influence the results obtained of patients' quality of life, including treatment methods 
and demographic conditions of the patient [7]. In a study conducted in India, the main factors affecting the 
QoL in the patients with head and neck cancer were weight loss, painkillers, viscous saliva, decreased mouth 
opening, and the eating disorders in public [5]. Pain in swallowing and problems were significantly higher in 
those who had radiotherapy and surgery [5]. In Pakistan, the mean score quality of individuals' lives before 
and after treatment of the head and neck cancer was observed in diarrhea, constipation, nausea/vomiting, and 
economic problems [8]. The highest complaint in the patients treated by the surgery was the numb and 
problem in speech and pain. The patients' most common side effects under chemotherapy with or without 
radiotherapy were weight loss and fatigue [9]. 
Quality of life in individuals with head and neck cancer was significantly worse than the beginning of 
the treatment in some cases, including gustatory sense, swallowing, and weight loss [10]. Previous authors 
showed that the pain severity had a direct effect on the QoL [11]. Quality of life in 30% of patients with 
squamous cell carcinoma was improper and the location and type of treatment had a role in reducing the QoL. 
The type of treatment had a significant effect on swallowing, pain and feeling illness [12]. Quality of life in the 
patients who had chemotherapy due to oropharyngeal cancer had higher scores in the fatigue, pain, problems of 
swallowing, eating in public, and inability for social reactions [13]. Knowing the relationships between QoL 
and potential determinants may assist with designing interventions aimed at improving QoL. 
Therefore in continuing our interest in dental and medical research [14-16], this study aimed to 
investigate the quality of life in the patients with head and neck cancer referred to one of the oncology centers 
in Mashhad, northeast of Iran, in 2019 based on EORTC-QLQ-H&N 35 Questionnaire, which has been the 
most valid questionnaire for investigating the oral dental side effects of cancer treatment and its impact on the 
patient's life [7,17]. Due to the lack of similar studies on the quality of life of patients with head and neck 
cancer, especially in Iran, this study was conducted to assess the impact of sociodemographic status, type and 
tumor location, patients'stage and type of tumor treatment on QoL. 
 
Material and Methods 
Study Design and Subjects 
This is a descriptive cross-sectional study conducted on individuals with head and neck cancer 
referred to one of the oncology centers in Mashhad in the northeast of Iran. 
The inclusion criteria were the patients over 18 years old and the patients with primary cancers of the 
head and neck area, and the individuals with reading and writing skills. The patients with skin cancers in the 
head and neck area were excluded from the study because of the nature of cancer and type of treatment. The 
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patients were taken oral satisfaction. The researcher visited the oncology center every morning from 
September 1 to the end of December 2019. Among the daily clients, the patients were selected by simple 
random sampling among clients with the inclusion criteria and were satisfied to participate in the plan. 
 
Data Collection 
Data were gathered through demographic characteristics (age, education level, and job). Patients’ 
education levels consisted of elementary, under diploma, diploma, upper diploma, license, upper license. 
Patients‘ job were asked based on the following: government's employee, worker, teacher, military, retired, free 
job and housewives. The information was related to the disease (type, clinical stage, type of treatment and area 
of cancer from patients’ records) and EORTC-H &N35 Quality of Life Questionnaire. 
The questionnaire consisted of 35 questions for achieving the quality of life-related to health 
developed in 7 sections (pain, swallowing, olfactory and gustatory sense, speech, eating in public, social 
communication and sex). The questionnaire has 11 items about dental problems, mouth opening, xerostomia, 
sticky saliva, coughing, restlessness, using painkillers, feeding tube, and weight changes, questions about 
demographic status and EORTC-H &N35 Quality of Life Questionnaire completed by patients. The answer to 
questions except for the questions of the individual’s status in the last week was scored as a four-point scale of 
never (one), sometimes (two), most times (three) and always (four). The higher score indicates the lower/worse 
quality of life [9,13]. According to the final scores obtained, three modes of good (less than 35), moderate (70-
35) and low (more than 70) quality of life were defined. 
 
Data Analysis 
Data analyzed by using t-test (comparison between gender and mean of QoL) and ANOVA 
(comparison mean of QoL and demographic variables) and linear regression (for multivariate analysis) by SPSS 
22 software (IBM Corp. in Armonk, NY, USA) at the significant level of 0.05. 
 
Ethical Clearance 
This research was approved with the Code (IR. KMU. REC. 1398.337) of by the Ethics Committee of 
Kerman University of Medical Sciences. 
 
Results 
Forty-nine subjects were male (72.1%) and 19 (27.9%) were female. The mean age was 60.48 ± 13.74 
years. Twenty-seven (39.7%) had a diploma degree. Fifteen participants (22.1%) were housewives and 27.9% 
were self-employed (Table 1). 
 
Table 1. Demographic characteristics of the sample. 
Variables N % Mean SD p-value 
Gender      
Male 49 72.1 41.11 20.62 0.517 
Female 19 27.9 45.14 18.79  
Age      
18-30 Years 8 11.7 43.92 16.22 0.046 
31-60 Years 26 38.3 44.17 12.51  
>60 years 34 50.0 49.32 19.67  
Educational Level      
Elementary 10 14.7 42.00 24.77 0.386 
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Under Diploma 16 23.5 41.33 17.96  
Diploma  27 39.7 47.64 19.30  
Upper Diploma 3 4.4 41.33 28.74  
License  8 11.8 43.12 24.56  
Upper License 4 5.9 20.75 8.38  
Job      
Employee 13 19.1 51.18 22.13 0.433 
Worker 1 1.4 54.00 -  
Teacher 6 8.8 52.50 16.26  
Military 2 2.9 32.50 1.60  
Retired 11 16.2 46.00 21.88  
Free Job 19 27.9 35.55 16.60  
House Wives 15 22.1 44.10 21.26  
 
Forty-nine (72.1%) had squamous cell carcinoma. In 38.2%, the lesion location was larynx and in 
35.3%, it was mouth. Forty-six (67.6%) were in clinical stage 3. Thirty-one individuals were in the treatment 
stages (45.6%). According to treatment time, 11.7% were at the beginning of treatment and 42.6% were in the 
process of completing treatment (Table 2). ANOVA test showed no significant relationship between the cancer 
location, type of cancer, and individuals' quality of life. A significant relationship was observed between the 
disease staging and type of treatment with quality of life. Individuals who had higher clinical staging and 
individuals who had all three treatments had worse quality of life, and this difference was significant. 
Regarding health status in the last week, 89.7% had used painkillers. Fifty-six subjects (82.4%) had used 
vitamin C and 70.6% had weight loss. 
 
Table 2. Correlation between cancer variables and mean score of quality of life. 
Variables N % Mean SD p-value 
Type of Cancer      
Sarcoma 5 7.4 44.40 24.09 0.592 
Adenocarcinoma 14 20.5 48.22 18.60  
Squamous Cell Carcinoma (SCC) 49 72.1 40.72 20.46  
Cancer Location      
Oral Cavity 24 35.3 40.05 18.88 0.503 
Pharynx 4 5.9 42.50 41.71  
Larynx  26 38.2 44.16 18.50  
Oropharynx 3 4.4 58.66 37.28  
Salivary Glands 11 16.1 36.00 18.06  
Clinical Stage      
I - - - - 0.004 
II 1 1.5 55.00 -  
III 46 67.6 36.60 19.26  
IV 18 26.5 55.62 17.18  
Type of Treatment      
Chemotherapy  3 4.4 35.00 19.00 0.020 
Radiotherapy 7 10.3 28.00 19.30  
Chemotherapy + Surgery 1 1.5 14.00 10.11  
Radiotherapy + Surgery 27 39.7 41.14 15.86  
Radiotherapy + Surgery + Chemotherapy 12 17.6 56.41 13.12  
Radiotherapy + Chemotherapy 17 25.0 41.56 24.77  
Surgery 1 1.5 40.21 -  
Time of Treatment      
Initiation 8 11.7 23.40 17.43 0.076 
During Treatment 31 45.6 40.41 16.70  
End of Treatment 29 42.6 45.27 21.97  
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The mean of the quality of life score was 42.06 ± 20.12. No significant difference was observed 
between the mean score of individuals' quality of life with gender. Multivariate analysis by Backward method 
showed that the disease staging (p=0.005), treatment type (p=0.041), using painkiller (p=0.037), and weight 
loss in the past week (p=0.030) caused the reduction of the quality of life in individuals (Table 3). 
 
Table 3. Prediction of QoL scores in the multivariate regression model. 
Variables B Beta t p-value 
Stage of Tumor 14.777 0.340 3.018 0.005 
Treatment Type 2.511 0.225 2.120 0.041 
Using Painkiller 15.237 0.283 2.161 0.037 
Weight Loss 12.636 0.291 2.259 0.030 
 
The patients who were chemotherapy with radiotherapy treatments had significantly more xerostomia 
problems (p=0.001). In the higher clinical stage, the patients had the worse quality of life in all areas of pain, 
swallowing, speech, eating, social, xerostomia, and marriage. Multivariate analysis was performed on each field 
of the quality of life and showed that type of treatment had a significant relationship with xerostomia and 
marital status and also social fields, eating problems, speech, swallowing and pain with clinical staging. 
The scoring of the quality of life levels based on weak, moderate and good has been shown in Figure 1. 
The quality of life was moderate in 47.1% of individuals. 
 
 
Figure 1. Frequency of patients based on level of quality of life. 
 
Discussion 
The QLQ-H&N35 questionnaire is a specific questionnaire to measure patients' quality of life with 
head and neck cancer. It has seven multi-question items that evaluate pain, swallowing ability, olfactory and 
gustatory sense, speech, social communication, and eating in public and marital relationships. Six items include 
the evaluating of dental problems, opening mouth, xerostomia, cough and weakness. The higher score indicates 
the worse quality of life in the patient [18]. 
Most patients with head and neck cancer were male 72.1% and the most common location was larynx 
(38.2%) in the current study. The study conducted in Brazil [11] showed that 87.4% of individuals were men 
and 60.6% of cases were the head and neck cancers in the mouth. In the study conducted by Rogers et al., 
63.3% of individuals were male and 71.2% of cases were cancer in the oral cavity [19]. In a study conducted by 
Liao et al. [18], 84% of individuals were male and 40% of cases were cancer in the oral cavity. 
A study conducted by Beck et al. [20] showed that 19.5% (46 individuals) of head and neck cancers 
were in the larynx and 23.3% (50 individuals) were in the oral cavity. In their study, 172 individuals (72.9%) 
30.9 
47.1 
8.8 
0 10 20 30 40 50 
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moderate  
good 
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were men. In the study in Iran, 75.4% of patients with head and neck cancer were male [21], which is 
consistent with the current study in terms of prevalence in males and the most common area of cancer (70.8%) 
was in larynx, which is consistent with the present study in terms of location [21]. 
The current most common type of oral cancer is SCC, which is consistent with the present study. The 
higher prevalence of cancer in larynx can be the low availability of the area for diagnosis by the individual and 
referral to the physician at the appropriate time. In the present study, the most common type of oral cancer was 
SCC, which is consistent with the study conducted by Rogers et al. [19] with the most common type (89.2%) 
and Zamanzadeh et al. [21], 97% of SCC cancer. 
In this study, none of the patients were in clinical stage 1 and 67.6% were in stage 3 of disease. In the 
research conducted by Oliveira et al. [11] and Zamanzadeh et al. [21], 19.6% and 32.4% were in clinical stage 
1, respectively, which is inconsistent with the present study. However, Liao et al. [18] found that 18% were in 
stage 3 and 39% were in stage 4. Considering that the number of patients with laryngeal carcinoma was higher 
than mouth, it can be mentioned that the late referral has increased the size and involvement of lymph nodes 
and, consequently, the higher clinical stage in the present study. 
The least treatment method was surgery and surgery with chemotherapy. Since oral lesions were less 
than other areas, cancer location has been the determinant of treatment methods. In the study conducted by 
Zamanzadeh et al. [21], the most common method of treatment (35.4%) was chemotherapy with radiotherapy, 
while Rogers et al. [19] found that the most common method was surgery. 
In this study, 89.7% of people have used painkillers in the last week. The study conducted by Cramer 
et al. [22] in patients with head and neck cancer 6.6 years after diagnosis showed that 45.1% of patients had 
pain. In the study conducted by Oliveira et al. [11], 66.9% of patients used painkillers for pain control. In the 
present study, those patients that use painkiller had significantly worse mean score of QoL. The cause of pain 
in the head and neck cancers is due to the direct effects of the tumor or, consequently, its treatment. The pains 
non-related with the tumor may contribute to the pain caused by the tumor in the patient's pain experience 
[23]. 
In the present study, those patients that didn't use tube feeding had significantly worse mean score of 
QoL. Nutrition impact symptoms negatively influence HNC patients. These symptoms are associated with 
decreased nutrition and quality of life. 
In terms of answering the questions, the best status of feeling pain in the jaw and the teeth' problem in 
terms of pain, hypersensitivity or color change, 31 people (45.6%) had selected all options. The type of cancer 
has had the least effect on the cases mentioned according to the cancer cases. In the current study, 86.8% of 
people complained of xerostomia more often or always. One study showed that 97.5% of individuals 
complained of xerostomia at the end of radiotherapy [24]. The xerostomia is one of the most common and 
unpleasant side effects of radiotherapy of head and neck cancers [25]. 
In this study, 54.4% responded always and most often to the question of eating problems and 65.2% 
had a problem with the hard food swallowing always and most often. Dysphagia is one of the common 
consequences of head and neck tumors [26]. In the study conducted by Caudell et al., 47% of patients had 
some degree of dysphagia [27]. In the present study, the mean score of the quality of life was 42.06 ± 20.12 
out of 90. 
There was no significant difference between gender and quality of life. The results are consistent with 
the other studies [12,21] that didn't observe a significant difference between males and females. But it is not 
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consistent with the findings from the study conducted by Liao et al. [18] that did not show a difference 
between gender and quality of life.  
Older people had a significantly lower quality of life. This may be because older people are generally 
more disabled than young people, and the problems caused by cancer and its treatment have a worsened effect 
on their quality of life. 
In the current study, marriage and job had no significant effect on the quality of life. The results are 
inconsistent with previous findings described by Liao et al. [18], which showed that marital status and low 
family income significantly affected the quality of life. 
The clinical stage had a significant effect on the quality of life of individuals in this study. A higher 
clinical stage had a worse quality of life. The results are consistent with other studies [12,21,28,29]. But Liao 
et al. [18] showed no significant difference between the clinical stage and the quality of life. In the study 
conducted by Torabi et al. [30], the clinical stage of the tumor did not have a significant relationship with the 
quality of life related to the oral health of individuals with head and neck cancer, which is not consistent with 
the present study; the reason can be the difference in the questionnaire used in both studies. 
In the present study, the treatment method had a significant effect on the patients' quality of life. The 
patients who had a combination of treatments had a lower QoL. It seems that the side effects of each treatment 
are combined and reduce the quality of life of individuals. The results are consistent with similar studies 
[12,21,31], but it is inconsistent with the study conducted by Indrapriyadharshini et al. [32], which did not 
show a significant relationship between the treatment methods of the quality of life score. It should be noted 
that the reason for this difference may be due to the different measurement tools in the current study. Among 
patients treated just by one method, the worst QoL was in surgery, followed by chemotherapy and 
radiotherapy. It may be due to surgical treatment that causes morbidity and can reduce patients’ quality of life. 
In the current study, no significant relationship was observed between the cancer location and the 
individuals' quality of life. However, the patients with oropharyngeal cancer had a worse quality of life. The 
results are consistent with similar studies [12,21,33] found that people with pharyngeal cancer had a worse 
quality of life. 
The weight loss and using painkillers caused the worse quality of life significantly, based on the 
multivariate test by Backward's method. It has been shown that swallowing problems persist long after the 
completion of chemotherapy/radiation therapy and it may decrease in the long term, but it does not return to 
its former state [34]; this issue may justify the weight loss and thus, worse quality of life of individuals. 
As this study was performed in only one center, it could not be generalized to all patients with head 
and neck cancer. It is recommended that the quality of life in patients with head and neck cancer to be 
evaluated using the different radiotherapy methods or special surgical and chemotherapy methods in future 
studies. 
 
Conclusion 
The findings of this study showed 47.1% of patients had a moderate quality of life. There was no 
significant relationship between gender, place, education and job with the quality of life. There was a 
significant relationship between the patients' age, the staging of disease and type of treatment with the quality 
of life. 
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